Detection of baloxavir resistant influenza A viruses using next generation sequencing and pyrosequencing methods

Baloxavir, a new antiviral drug targeting cap-dependent endonuclease activity of polymerase acidic (PA) protein of influenza viruses, is now approved in multiple countries. Several substitutions at isoleucine 38 in PA protein (e.g., PA-I38T) have been associated with decreased baloxavir susceptibili...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antiviral Res
Autors principals: Patel, Mira C., Mishin, Vasiliy P., De La Cruz, Juan A., Chesnokov, Anton, Nguyen, Ha T., Wilson, Malania M., Barnes, John, Kondor, Rebecca J.G., Wentworth, David E., Gubareva, Larisa V.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7426223/
https://ncbi.nlm.nih.gov/pubmed/32798601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2020.104906
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars